Literature DB >> 3917570

Benefits of the CO2 laser in oral hemangioma excision.

D B Apfelberg, M R Maser, H Lash, D N White.   

Abstract

Twenty-one patients with small localized oral cavity hemangiomas of the lips, tongue, and buccal mucosa are reported in this series. Although the lesions were not massive or high-flow/high-pressure vascular tumors, the simultaneous cutting and coagulation capabilities of the CO2 laser were demonstrated, rendering such excisional surgery more precisely and easily accomplished with a great deal less bleeding and a marked reduction in postoperative pain and edema. Many of the patients in this series were done as outpatients under local anesthesia. Results were acceptable and complications were minimal. Thus this laser is recommended both for the patient care and comfort aspects and the ability to render oral cavity hemangioma excisional surgery much more safely and easily done with a significant decrease in hospital utilization and overall medical expenses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917570     DOI: 10.1097/00006534-198501000-00010

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

1.  Aesthetic Treatment Outcomes of Capillary Hemangioma, Venous Lake, and Venous Malformation of the Lip Using Different Surgical Procedures and Laser Wavelengths (Nd:YAG, Er,Cr:YSGG, CO2, and Diode 980 nm).

Authors:  Samir Nammour; Marwan El Mobadder; Melanie Namour; Amaury Namour; Josep Arnabat-Dominguez; Kinga Grzech-Leśniak; Alain Vanheusden; Paolo Vescovi
Journal:  Int J Environ Res Public Health       Date:  2020-11-22       Impact factor: 3.390

2.  Results of a unilateral lip lift for correction of a vertical disproportion in upper lip vascular anomalies.

Authors:  Shahriar Loghmani; Amir Momeni; Mohammad Eidy
Journal:  Indian J Plast Surg       Date:  2009 Jan-Jun

3.  Treatment of Vascular Lesions of the Tongue with Nd:YAG Laser.

Authors:  Joana Dias Coelho; Vasco Serrão
Journal:  Case Rep Med       Date:  2009-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.